Glaukos Competitors and Similar CompaniesClear all
Glaukos's competitors and similar companies include Haemonetics, ARTIVION, Livanova and Exactech.
 Glaukos Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases. |  ARTIVION CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair. | ||||
Founding Date | Founding Date 1998 | Founding Date 1971 | Founding Date 1984 | Founding Date 2015 | Founding Date 1985 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Aliso Viejo, US HQ Buenos Aires, AR Heatherton, AU Sao Paulo, BR Richmond Hill, CA San José, CR Wiesbaden, DE see more | Locations Kennesaw, US HQ Paris, FR Singapore, SG Guildford, GB Austin, US | Locations London, GB HQ Dandenong South, AU Wien, AT Markham, CA Bogotá, CO Helsinki, FI Helsinki, FI see more | Locations Gainesville, US HQ Castle Hill, AU Mérignac, FR Meylan, FR Kiel, DE Brescia, IT Tokyo, JP see more | |
Employees | Employees 90716% increase | Employees 3,65721% increase | Employees 1,2009% increase | Employees 2,900 | Employees 9891% decrease |
Valuation ($) | Valuation ($) 7.6 b | Valuation ($) 3.7 b | Valuation ($) 1.1 b | Valuation ($) 2.9 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $507.4m (FY, 2025) | Revenue (est.) $1.3b (FY, 2026) | Revenue (est.) $441.3m (FY, 2025) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $111.8m (FY, 2025) | Cost of goods $546.4m (FY, 2026) | Cost of goods $157.1m (FY, 2025) | Cost of goods $448.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $282.8m (FY, 2025) | Gross profit $787.6m (FY, 2026) | Gross profit $284.2m (FY, 2025) | Gross profit $939.9m (FY, 2025) | Gross profit N/A |
Net income | Net income ($187.7m) (FY, 2025) | Net income $97.3m (FY, 2026) | Net income $9.8m (FY, 2025) | Net income ($242.5m) (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Facility Space Leased, sq. ft. | Facility Space Leased, sq. ft. 318 k (FY, 2022) | Facility Space Leased, sq. ft. 885.4 k (FY, 2023) | Facility Space Leased, sq. ft. N/A | Facility Space Leased, sq. ft. N/A | Facility Space Leased, sq. ft. N/A |
Funding | |||||
Total funding raised | Total funding raised $ 115m | Total funding raised N/A | Total funding raised $ 1.3m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Haemonetics
HQ
Boston, US
Employees
3,657↑ 21% increase
Haemonetics is a provider of medical products and solutions.
View companyARTIVION
HQ
Kennesaw, US
Employees
1,200↑ 9% increase
CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair.
View company
Exactech
HQ
Gainesville, US
Exactech is a manufacturer of implants and smart technologies for joint replacement.
View company